Blues health insurers put up $55 million to take on generic drug makers
NEW YORK (Reuters) - A group of Blue Cross Blue Shield insurers is investing $55 million in a venture that ...
Tag: Healthcare (TRBC level 1)
DCGI orders suspension of Serum’s India trials of AstraZeneca’s COVID-19 vaccine
(Reuters) - India's drug regulator has asked Serum Institute of India to suspend recruitment in its clinical trials of AstraZeneca ...
Factbox: How AstraZeneca-Oxford developed Britain’s home-grown COVID-19 vaccine
(Reuters) - AstraZeneca said on Tuesday it will publish up-to-date results from its latest COVID-19 vaccine trial after U.S. health ...
Today Trend News
Fianance
